$AVD

AMERICAN VANGUARD CORP

American Vanguard operates as a holding company through subsidiaries that manufacture, formulate, distribute and sell chemical, biological and biorational products for agricultural, commercial and consumer uses. Its products include insecticides, fungicides, herbicides, soil health and plant nutrition products, and products for turf, ornamental plants, and human and animal health protection. AMVAC, its main operating subsidiary, makes and markets products in liquid, powder and granular forms, including through SmartBox Plus, Lock ‘n Load and EZ Load delivery systems. The company has one reportable segment. American Vanguard also operates GemChem, which sells into pharmaceutical, cosmetic and nutritional markets; OHP, which markets end-use products for the turf and ornamental market; and TyraTech, which primarily licenses intellectual property for pesticide products and technologies. International subsidiaries sell and distribute products across multiple territories. The company sells directly, through subsidiaries and distributors, and by licensing intellectual property. American Vanguard is headquartered in Newport Beach, California.

AlphAI earnings readQ3 FY2026 · NOV 10American Vanguard reports Q3 2026 net loss of $(17,668) thousand, net sales down 9%, and a revised full-year outlookVerdict: weak

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
0
8

No SEC Form 4 filings for $AVD in the last 30 days.

See all $AVD insider activity →
Med

American Vanguard Reports Third Quarter 2026 Results

AMERICAN VANGUARD CORP (AVD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE American Vanguard Reports Third Quarter 2026 Results Strategic Deals in Quarter Expand U.S. Product Portfolio Consolidation Driving Manufacturing Efficiency Gains El Nino and Geopolitics Pressure Global Agricultural Markets Irvine, CA | November

American Vanguard Corp (AVD) (Q3 2026) Earnings Call Highlights: Cost Savings and New

American Vanguard Corp (AVD) reported Q3 2026 earnings, highlighting 44% YoY increase in customer prepayments, $4.5M annual cost savings, and 10 new product launches. The company expects Q4 net sales of $166M (up 10%) and adjusted EBITDA of $21M (up 25%). However, full-year guidance was lowered due to international sales decline, higher costs, and market challenges. The company's gross leverage ratio is 6.5 times, near its covenant maximum.

AVD sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 8 news stories mentioning AVD (AMERICAN VANGUARD CORP). Coverage has skewed bearish: 0 bullish, 0 neutral, and 8 bearish.

Recent AVD coverage spans earnings, financial news and insider activity.

What's driving AVD

AlphAI scores every news story that mentions AVD with an AI model for sentiment and relevance, and aggregates insider trades from AMERICAN VANGUARD CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AVD

Score

American Vanguard Reports Third Quarter 2026 Results

AMERICAN VANGUARD CORP (AVD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE American Vanguard Reports Third Quarter 2026 Results Strategic Deals in Quarter Expand U.S. Product Portfolio Consolidation Driving Manufacturing Efficiency Gains El Nino and Geopolitics Pressure Global Agricultural Markets Irvine, CA | November

American Vanguard Corp (AVD) (Q3 2026) Earnings Call Highlights: Cost Savings and New

American Vanguard Corp (AVD) reported Q3 2026 earnings, highlighting 44% YoY increase in customer prepayments, $4.5M annual cost savings, and 10 new product launches. The company expects Q4 net sales of $166M (up 10%) and adjusted EBITDA of $21M (up 25%). However, full-year guidance was lowered due to international sales decline, higher costs, and market challenges. The company's gross leverage ratio is 6.5 times, near its covenant maximum.

AMERICAN VANGUARD CORP (AVD): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

AMERICAN VANGUARD CORP (AVD) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 American Vanguard Corporation (AVD) Announces CFO Transition Irvine, CA | October 1, 2026 — American Vanguard Corporation (NYSE: AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and

American Vanguard Corporation Announces Executive Appointment of Mark Helt as U.S. Crop President

American Vanguard Corporation (NYSE:AVD) said Mark Helt has joined as U.S. Crop President. The company said he brings 25+ years of commercial leadership from Albaugh, including U.S. crop protection and seed treatment, and prior roles at Bayer Crop Science and Monsanto. He reports to Chief Commercial Officer Mike DiPaola and will oversee U.S. crop strategy and financial performance.

American Vanguard Reports Second Quarter 2026 Results

AMERICAN VANGUARD CORP (AVD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE American Vanguard Reports Second Quarter 2026 Results First-Half Gross Profit Increased 3%, and EBITDA Increased 21% on Mostly Flat Sales Reaffirm Full-Year Outlook; Adjusted EBITDA $44 million to $48 million on Sales of $530 million to $550 mil

$AVDMedAI 8/10

American Vanguard (AVD) Q2 2026 Earnings Call Transcript

American Vanguard (AVD) reported Q2 2026 net sales of $117 million, down from $129 million in Q2 2025. International sales fell 18% in the quarter, while specialty revenue rose 11%. Adjusted EBITDA was $0.6 million versus $11 million a year earlier. 2026 guidance calls for revenue of $530 million to $550 million and adjusted EBITDA of $44 million to $48 million.

American Vanguard Reports Second Quarter 2026 Results

American Vanguard Corporation reported Q2 2026 net sales of $117 million versus $129 million in Q2 2025, with gross margin at 30% versus 31%. The company posted an operating loss of $0.30 million and net loss of $9.9 million. Adjusted EBITDA was $6.6 million. For 2026, it reaffirmed guidance of adjusted EBITDA $44 million to $48 million on sales of $530 million to $550 million.

Related tickers